Insider track record
OtherAcross 1 buy signal with a settled T+90 return. Return basis: close on the day after publication.
Discover the full record of transactions filed by Devroe Eric. Insider active across 1 company, notably Acrivon Therapeutics, Inc.. Aggregated, 11 reports have been logged. History available since 14 November 2022. The latest transaction was disclosed on 14 November 2025 (Retenue fiscale). Regulator: SEC (Form 4). The full history is openly available.
Declarations11 total
613 shares@ US$2.242.3% of flowCommon StockSEC:0000905148-25-004128:0
613 shares@ US$1.141.2% of flowCommon StockSEC:0000905148-25-001821:0
724 shares@ US$5.427.3% of flowCommon StockSEC:0000905148-25-000726:0
613 shares@ US$7.929.0% of flowCommon StockSEC:0000905148-24-003224:0
613 shares@ US$7.027.6% of flowCommon StockSEC:0000905148-24-002278:0
10,000 shares@ US$1.0418.7% of flowCommon StockSEC:0000905148-24-001566:0
613 shares@ US$8.369.2% of flowCommon StockSEC:0000905148-24-001485:0
723 shares@ US$3.404.5% of flowCommon StockSEC:0000905148-24-000761:0
2,450 shares@ US$5.0822.7% of flowCommon StockSEC:0000905148-23-001473:0
9,225 shares@ US$1.0417.5% of flowCommon StockSEC:0001140361-23-028539:0
33,383 shares0Common StockSEC:0001209191-22-057399:0